vs
Side-by-side financial comparison of Dime Community Bancshares, Inc. (DCOM) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Dime Community Bancshares, Inc. is the larger business by last-quarter revenue ($123.8M vs $92.9M, roughly 1.3× Vericel Corp). On growth, Dime Community Bancshares, Inc. posted the faster year-over-year revenue change (3040.1% vs 23.3%). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 22.9%).
The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
DCOM vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $92.9M |
| Net Profit | — | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 38.6% | 24.1% |
| Net Margin | — | 25.0% |
| Revenue YoY | 3040.1% | 23.3% |
| Net Profit YoY | — | 17.3% |
| EPS (diluted) | $0.68 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $92.9M | ||
| Q3 25 | $115.6M | $67.5M | ||
| Q2 25 | $109.7M | $63.2M | ||
| Q1 25 | $103.8M | $52.6M | ||
| Q4 24 | $3.9M | $75.4M | ||
| Q3 24 | $87.6M | $57.9M | ||
| Q2 24 | $87.3M | $52.7M | ||
| Q1 24 | $82.0M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $27.7M | $5.1M | ||
| Q2 25 | $29.7M | $-553.0K | ||
| Q1 25 | $21.5M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $13.3M | $-901.0K | ||
| Q2 24 | $18.5M | $-4.7M | ||
| Q1 24 | $17.7M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 38.6% | 24.1% | ||
| Q3 25 | 34.7% | 5.1% | ||
| Q2 25 | 36.6% | -3.2% | ||
| Q1 25 | 27.6% | -24.3% | ||
| Q4 24 | -433.6% | 24.5% | ||
| Q3 24 | 20.8% | -4.3% | ||
| Q2 24 | 29.8% | -11.5% | ||
| Q1 24 | 29.6% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | 23.9% | 7.5% | ||
| Q2 25 | 27.1% | -0.9% | ||
| Q1 25 | 20.7% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 15.2% | -1.6% | ||
| Q2 24 | 21.2% | -8.9% | ||
| Q1 24 | 21.6% | -7.5% |
| Q4 25 | $0.68 | $0.46 | ||
| Q3 25 | $0.59 | $0.10 | ||
| Q2 25 | $0.64 | $-0.01 | ||
| Q1 25 | $0.45 | $-0.23 | ||
| Q4 24 | $-0.58 | $0.40 | ||
| Q3 24 | $0.29 | $-0.02 | ||
| Q2 24 | $0.43 | $-0.10 | ||
| Q1 24 | $0.41 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $354.6M |
| Total Assets | $15.3B | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $1.5B | $354.6M | ||
| Q3 25 | $1.5B | $321.9M | ||
| Q2 25 | $1.4B | $306.8M | ||
| Q1 25 | $1.4B | $295.5M | ||
| Q4 24 | $1.4B | $292.0M | ||
| Q3 24 | $1.3B | $257.5M | ||
| Q2 24 | $1.3B | $243.0M | ||
| Q1 24 | $1.2B | $233.9M |
| Q4 25 | $15.3B | $488.0M | ||
| Q3 25 | $14.5B | $453.3M | ||
| Q2 25 | $14.2B | $435.6M | ||
| Q1 25 | $14.1B | $424.6M | ||
| Q4 24 | $14.4B | $432.7M | ||
| Q3 24 | $13.7B | $390.4M | ||
| Q2 24 | $13.5B | $376.8M | ||
| Q1 24 | $13.5B | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $186.6M | $15.0M |
| Free Cash FlowOCF − Capex | — | $12.8M |
| FCF MarginFCF / Revenue | — | 13.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $186.6M | $15.0M | ||
| Q3 25 | $52.1M | $22.1M | ||
| Q2 25 | $23.1M | $8.2M | ||
| Q1 25 | $65.4M | $6.6M | ||
| Q4 24 | $99.1M | $22.2M | ||
| Q3 24 | $-33.3M | $10.2M | ||
| Q2 24 | $12.6M | $18.5M | ||
| Q1 24 | $30.7M | $7.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $51.2M | $19.5M | ||
| Q2 25 | $20.4M | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $-34.1M | $-9.2M | ||
| Q2 24 | $9.2M | $1.8M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | 13.8% | ||
| Q3 25 | 44.3% | 28.8% | ||
| Q2 25 | 18.6% | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | -38.9% | -15.9% | ||
| Q2 24 | 10.5% | 3.4% | ||
| Q1 24 | — | -13.3% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | 0.7% | 3.9% | ||
| Q2 25 | 2.4% | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | 0.9% | 33.5% | ||
| Q2 24 | 3.9% | 31.8% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 1.88× | 4.35× | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DCOM
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
